Type 1 Diabetes and COVID-19: A Literature Review and Possible Management.

Kebria KashfiNarges AnbardarArtin AsadipooyaKamyar Asadipooya

Published in: International journal of endocrinology and metabolism (2023)

Combining medications that reduce SARS-CoV-2 entry into the cells and modulate the immune response to infection is an alternative practical approach to treating COVID-19.

Keyphrases

sars cov
type diabetes
immune response
coronavirus disease
respiratory syndrome coronavirus
induced apoptosis
cell cycle arrest
case report
cardiovascular disease
endoplasmic reticulum stress
signaling pathway
cell death
metabolic syndrome
oxidative stress
adipose tissue
skeletal muscle
pi k akt